Atherosclerotic plaque destabilization in Mice: A comparative study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Hartwig, Helene ^a   Silvestre Roig, Carlos ^a,b   Hendrikse, Jeffrey ^a   Beckers, Linda ^a   Paulin, Nicole ^b   Van Der Heiden, Kim ^c   Braster, Quinte ^a   Drechsler, Maik ^a,b   Daemen, Mat J ^a   Lutgens, Esther ^a,b   Soehnlein, Oliver ^a,b,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; ATHEROSCLEROTIC PLAQUE DESTABILIZATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOLOGY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INCIDENCE; MALE; MOUSE; NONHUMAN; SHEAR STRESS; ANIMAL; ATHEROSCLEROSIS; CLASSIFICATION; COMMON CAROTID ARTERY; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; KIDNEY ARTERY; KNOCKOUT MOUSE; LIPID DIET; MECHANICAL STRESS; PATHOLOGY; RENOVASCULAR HYPERTENSION; SURGERY;

APOLIPOPROTEIN E;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HYPERCHOLESTEROLEMIA; HYPERTENSION, RENOVASCULAR; MALE; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RENAL ARTERY; STRESS, MECHANICAL;

EID: 84949434644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141019     Document Type: Article

References (22)

1. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: The pathologists' view2013 2013-03-07 00:00:00. 719-28 p.
2. Libby P. Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy. New England Journal of Medicine. 2013; 368(21):2004-13. doi: 10.1056/NEJMra12160635.
3. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I. Circulation. 2003; 108(14):1664-72. doi: 10.1161/01.cir.0000087480.94275.975
4. Silvestre-Roig C, de Winther MP, Weber C, Daemen MJ, Lutgens E, Soehnlein O. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res. 2014; 114(1):214-26.4. doi: 10.1161/CIRCRESAHA.114.302355
5. Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque Rupture in Humans and Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007; 27(4):705-13. doi: 10.1161/01.atv.0000261709.34878.203
6. Jackson CL, Bennett MR, Biessen EAL, Johnson JL, Krams R. Assessment of Unstable Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007; 27(4):714-20. doi: 10.1161/01. ATV.0000261873.86623.e12
7. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Shibata T, Sato K, et al. A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology. 2006; 26(6):1304-9.4.
8. Jin SX, Shen LH, Nie P, Yuan W, Hu LH, Li DD, et al. Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology. 2012; 32(10):2372-9.3. doi: 10.1161/ATVBAHA. 111.236158
9. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006; 113 (23):2744-53.2.
10. Sullivan CJ, Hoying JB. Flow-Dependent Remodeling in the Carotid Artery of Fibroblast Growth Factor-2 Knockout Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2002; 22(7):1100-5. doi: 10. 1161/01.atv.0000023230.17493.e33
11. Goodpaster T, Randolph-Habecker J. A flexible mouse-on-mouse immunohistochemical staining technique adaptable to biotin-free reagents, immunofluorescence, and multiple antibody staining. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2014; 62(3):197-204. Epub 2013/10/25. doi: 10.1369/00221554135116204
12. Shiomi M, Ito T, Hirouchi Y, Enomoto M. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Atherosclerosis. 2001; 157(1):75-84. Epub 2001/06/28.6.
13. Newby AC. Matrix metalloproteinase inhibition therapy for vascular diseases. Vascular pharmacology. 2012; 56(5-6):232-44. Epub 2012/02/14. doi: 10.1016/j.vph.2012.01.0078.
14. Hellings WE, Peeters W, Moll FL, Piers SR, van Setten J, Van der Spek PJ, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: A prognostic study. Circulation. 2010; 121(17):1941-50. Epub 2010/04/21. doi: 10.1161/CIRCULATIONAHA.109.887497 CIRCULATIONAHA. 109.887497 [pii].6.
15. Peter K, Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, et al. A Novel Mouse Model of Atherosclerotic Plaque Instability for Drug Testing and Mechanistic/Therapeutic Discoveries Using Gene and microRNA Expression Profiling. Circ Res. 2013.0. doi: 10.1161/CIRCRESAHA.114. 302347
16. Bentzon JF, Falk E. Atherosclerotic lesions in mouse and man: is it the same disease? Curr Opin Lipidol. 2010; 21(5):434-40.7. doi: 10.1097/MOL.0b013e32833ded6a
17. Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation. 2005; 111(11):1422-30.3.
18. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis. 2001; 154(2):399-406.2.
19. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003; 362(9395):1527-35.7.
20. Yang JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, et al. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arteriosclerosis, thrombosis, and vascular biology. 2013; 33(8):1978-85.8. doi: 10.1161/ATVBAHA.113.301320
21. Koboziev I, Jones-Hall Y, Valentine JF, Reinoso Webb C, Furr KL, Grisham MB. Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases. Inflammatory bowel diseases. 2015; 21(7):1652-73. Epub 2015/06/03. doi: 10.1097/mib.00000000000004466
22. Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty SV, Teichmann LL, et al. Development and function of human innate immune cells in a humanized mouse model. Nat Biotech. 2014; 32(4):364-72. doi: 10.1038/nbt.2858 http://www.nature.com/nbt/journal/v32/n4/abs/nbt.2858.html#supplementaryinformation.